14 Jul 2026
Industry Insight: June 2026 Update: Health Canada Provides Updates on Human Drug Submission Workload Management

Industry Insight: June 2026 Update: Health Canada Provides Updates on Human Drug Submission Workload Management

Canadian Drug Regulations, , , , , , , ,
As of June 2026, Health Canada is advancing workload management measures intended to address human drug submission backlogs, improve review predictability, and support more transparent communication with sponsors. These measures include enhanced communication protocols, expanded reliance approaches, HTA alignment, and operational review efficiencies, while maintaining Health Canada’s review standards for…
Read More
11 Mar 2025
Health Canada’s New NHP Management Process: 2025 Updates You Should Know

Health Canada’s New NHP Management Process: 2025 Updates You Should Know

Natural Health Products (NHPs), , , ,
Health Canada has introduced important updates to the management of Natural Health Products (NHPs) to enhance efficiency in the approval process. These changes specifically affect Class III NHP submissions, which will now be prioritized based on whether the products are being sold or manufactured in Canada. By focusing on these…
Read More
05 Mar 2025
Health Canada Proposes Temporary Exemptions for NHP Labelling Requirements

Health Canada Proposes Temporary Exemptions for NHP Labelling Requirements

Natural Health Products (NHPs), , , , ,
On February 25, 2027, Health Canada announced a Notice of Intent to introduce a Ministerial Order that would temporarily exempt certain Natural Health Products (NHPs) from specific labelling provisions set to take effect in June 2025. This proposal aims to address implementation challenges faced by the industry while maintaining consumer…
Read More